BeOne Medicines (ONC) Operating Income (2016 - 2025)
Historic Operating Income for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $163.1 million.
- BeOne Medicines' Operating Income rose 23562.88% to $163.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.7 million, marking a year-over-year increase of 12093.54%. This contributed to the annual value of -$568.2 million for FY2024, which is 5295.34% up from last year.
- According to the latest figures from Q3 2025, BeOne Medicines' Operating Income is $163.1 million, which was up 23562.88% from $87.9 million recorded in Q2 2025.
- In the past 5 years, BeOne Medicines' Operating Income ranged from a high of $190.6 million in Q4 2021 and a low of -$474.8 million during Q2 2021
- In the last 5 years, BeOne Medicines' Operating Income had a median value of -$261.3 million in 2024 and averaged -$209.5 million.
- Its Operating Income has fluctuated over the past 5 years, first plummeted by 73175.99% in 2022, then skyrocketed by 23562.88% in 2025.
- Quarter analysis of 5 years shows BeOne Medicines' Operating Income stood at $190.6 million in 2021, then tumbled by 345.92% to -$468.6 million in 2022, then increased by 18.1% to -$383.8 million in 2023, then skyrocketed by 79.31% to -$79.4 million in 2024, then surged by 305.37% to $163.1 million in 2025.
- Its last three reported values are $163.1 million in Q3 2025, $87.9 million for Q2 2025, and $11.1 million during Q1 2025.